PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 112 filers reported holding PROVENTION BIO INC in Q1 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,874,378 | +233031.6% | 77,775 | +2.2% | 0.00% | – |
Q4 2022 | $804 | -99.8% | 76,109 | -0.6% | 0.00% | – |
Q3 2022 | $344,000 | +7.5% | 76,581 | -4.3% | 0.00% | – |
Q2 2022 | $320,000 | +36.2% | 80,042 | +149.1% | 0.00% | – |
Q1 2022 | $235,000 | +29.8% | 32,131 | 0.0% | 0.00% | – |
Q4 2021 | $181,000 | – | 32,131 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |